| Literature DB >> 19607722 |
Daniel M Chisenhall1, Christopher N Mores.
Abstract
BACKGROUND: West Nile virus (WNV) has spread across North, Central, and South America since its introduction in 1999. At the start of this spread, Florida was considered a potentially important area with regards to transmission due to its geographic, climatological, and demographic conditions. Curiously, the anticipated high levels of transmission or disease outbreaks have not been observed. As other studies have predicted that the lack of intense WNV transmission is not due to vector incompetence, we sought to evaluate the role of viral strain diversity in WNV transmission in Florida. Therefore, a phylogentic analysis was carried out on several isolates collected from three distinct locations in Florida.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19607722 PMCID: PMC2720385 DOI: 10.1186/1743-422X-6-106
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
West Nile virus collection information. Positive mosquito pool numbers, locations, and dates of collection.
| Isolate Number | County Collected (FL) | Date Collected |
| 351 | Duvall | 23Aug2005 |
| 493 | Duvall | 30Aug2005 |
| 510 | Duvall | 30Aug2005 |
| 522 | Duvall | 30Aug2005 |
| 558 | Manatee | 1Sept2005 |
| 967 | Duvall | 20Sept2005 |
| 1102 | Duvall | 30Sept2005 |
| 2186 | Indian River | 1Nov2005 |
Primers.
| Forward Primer | Reverse Primer | |
| Envelope 1st | 5'-GAAGGCGATAGTTGTGTGACCA-3' | 5'-TGTTCCCTTCAGCTGCAACTT-3' |
| Envelope 2nd | 5'-CCTTGGAGCAGTGCTGGAAGTA-3' | 5'-TTCACGGAGAGGAAGAGCAGAA-3' |
| NS3 1st | 5'-CGGCTCATACATAAGCGCGAT-3' | 5'-TTGGTTTCACACTCTTCCGGC-3' |
| NS3 2nd | 5'-TTCCACAAAGGTCGAGCTAGG-3' | 5'-CCTAGGACCATCAAAGCACCA-3' |
| NS3 3rd | 5'-CCATCTGCAGTGACAGCAGCTA-3' | 5'-TTCGTTCCTGGAACTTCAGCC-3' |
Primer sequences used to sequence the envelope and NS3 regions of the samples.
*NT positions refer to amplicon location with respect to "WNV RNA, Complete Genome" GenBank accession number M12294
GenBank reference sequence information.
| Abbreviation | Year of Isolation | Location | Source | GenBank accession no. |
| 1998 Isreael | 1998 | Israel | ||
| NY99 | 1999 | Bronx Co., NY | ||
| 2001 Suffolk NY | 2001 | Suffolk Co., NY | ||
| 2002 Nassau NY | 2002 | Nassau Co., NY | ||
| 2002 Queens NY | 2002 | Queens Co., NY | ||
| 2002 Indiana | 2002 | Indiana | Human – Plasma | |
| 2002 Ohio | 2002 | Ohio | Human – Plasma | |
| 2002 Georgia 1 | 2002 | Georgia | Human – Plasma | |
| 2002 Georgia 2 | 2002 | Georgia | Human – Brain | |
| 2002 Clinton NY | 2002 | Clinton Co., NY | ||
| 2002 Texas 2 | 2002 | Texas | Human – Plasma | |
| 2002 Texas 1 | 2002 | Texas | Human – Plasma | |
| 2002 Broome NY | 2002 | Broome Co., NY | ||
| 2003 Albany NY | 2003 | Albany Co., NY | ||
| 2003 Suffolk NY | 2003 | Suffolk Co., NY | ||
| 2003 Colorado 1 | 2003 | Colorado | ||
| 2003 Mexico | 2003 | Nuevo Leon, Mexico | ||
| WN-FL03p2-3 | 2003 | Indian River Co., FL | ||
| 2003 Colorado 2 | 2003 | Colorado | ||
| 2003 Chautauqua NY | 2003 | Chautauqua Co., NY | ||
| 2003 Texas | 2003 | Texas | Human – Plasma | |
| 2003 Rockland NY | 2003 | Rockland Co., NY | ||
| 2003 Westchester NY | 2003 | Westchester Co., NY | ||
| 2004 Arizona | 2004 | Arizona | Human – Plasma | |
| 2004 Texas – Harris | 2004 | Harris Co., TX |
West Nile virus isolates used in the construction of the Envelope and NS3/NS4A phylogentic trees.
*NT positions refer to amplicon location with respect to "WNV RNA, Complete Genome" GenBank accession number
Figure 1NS3/NS4A phylogenetic tree. Phylogenetic tree constructed using the sequenced portion of NS3/NS4A (1611 nucleotides) of the isolates collected in Florida in 2005 and the corresponding sequences of reference files in Genbank (table 3).
Figure 2Envelope phylogenetic tree. Phylogenetic tree constructed using the sequenced portion of envelope protein (1296 nucleotides) of the isolates collected in Florida in 2005 and the corresponding sequences of reference files in Genbank (table 3).
Nucleotide and amino acid sequence comparison of the eight WNV isolates collected in Florida during 2005.
| No. nucleotide bases | ||||
| Gene | Analyzed | Variable | Informative* | Mean Nucleotide Distance (%) |
| Envelope | 1296 | 72 | 17 | 0.46 |
| NS3/4A | 1611 | 85 | 22 | 0.49 |
| No. amino acid residues | ||||
| Gene | Analyzed | Variable | Informative* | Mean Amino Acid Distance (%) |
| Envelope | 432 | 23 | 7 | 0.50 |
| NS3/4A | 537 | 17 | 3 | 0.22 |
*Phylogenetically informative (differences occurring in two or more isolates) nucleotide and amino acid sites.
Mean genetic distances between and within groups using the isolates from Florida in 2005 as a subgroup.
| Mean genetic distance* ± SE | ||||
| Envelope | NS3/4A | |||
| Type of comparison | NT | AA | NT | AA |
| Within Florida 2005 | 0.0086 ± 0.0016 | 0.0101 ± 0.0027 | 0.0064 ± 0.0012 | 0.0044 ± 0.0016 |
| Within all other regions and times | 0.0028 ± 0.0005 | 0.0028 ± 0.0012 | 0.0039 ± 0.0006 | 0.0015 ± 0.0005 |
| Between Florida 2005 and all other regions and times | 0.0064 ± 0.0010 | 0.0071 ± 0.0017 | 0.0061 ± 0.0009 | 0.0031 ± 0.0009 |
* = NT, nucleotide; AA, amino acid.
Figure 3West Nile virus envelope protein model. The histadines are noted and residues of interest boxed.
Mean genetic distances between and within groups using the isolates from Florida in 2005 and New York from 2001 to 2003 as separate subgroups.
| Mean genetic distance* ± SE | ||||
| Envelope | NS3/4A | |||
| Type of comparison | NT | AA | NT | AA |
| Within New York (01–03) | 0.0024 ± 0.0007 | 0.0031 ± 0.0015 | 0.0035 ± 0.0007 | 0.0011 ± 0.0006 |
| Within Florida 2005 | 0.0086 ± 0.0015 | 0.0101 ± 0.0027 | 0.0064 ± 0.0012 | 0.0044 ± 0.0016 |
| Within all other regions and times | 0.0035 ± 0.0007 | 0.0033 ± 0.0014 | 0.0041 ± 0.0007 | 0.0017 ± 0.0007 |
| Between New York (01–03) and Florida 2005 | 0.0062 ± 0.0010 | 0.0073 ± 0.0019 | 0.0059 ± 0.0009 | 0.0029 ± 0.0009 |
| Between New York (01–03) and all other regions and times | 0.0030 ± 0.0005 | 0.0032 ± 0.0013 | 0.0039 ± 0.0006 | 0.0014 ± 0.0005 |
| Between Florida 2005 and all other regions and times | 0.0067 ± 0.0011 | 0.0072 ± 0.0018 | 0.0062 ± 0.0010 | 0.0032 ± 0.0009 |
* = NT, nucleotide; AA, amino acid.